Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Amgen Inc

02 1Viela Bio

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inebilizumab

Brand Name : Uplizna

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 25/04/2022

Application Number : 20201124000059

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inebilizumab

Brand Name : Uplizna

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/10ml

Packaging :

Approval Date : 04/03/2024

Application Number : 69322

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INEBILIZUMAB

Brand Name : UPLIZNA

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 2543931

Regulatory Info : Schedule D

Registration Country : Canada

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inebilizumab

Brand Name : Uplizna

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2022-07-22

Application Number : 1211602001

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INEBILIZUMAB-CDON

Brand Name : UPLIZNA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/10ML

Packaging :

Approval Date :

Application Number : 761142

Regulatory Info :

Registration Country : USA

blank